Quoin Pharmaceuticals, Ltd.: cashflow_investing
| Value | {"amount": -4465774, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | Quoin Pharmaceuticals, Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:09:31.173256+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6665c9c6-d542-418f-92ad-bdc86bc8a994
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-24-000701Retrieved: 2026-08-19T17:09:31.173256+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001671502/cashflow-investing/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6665c9c6-d542-418f-92ad-bdc86bc8a994
History
- no predecessors — first report